# SAM #19AQMM26F1490 

Sole-source order for Sanofi Fluzone and Flublok influenza vaccines

**Buyer:** Bureau of Administration Acquisitions Division
**Posted:** October 21, 2026
**Identifier:** 19AQMM26F1490
**NAICS:** 325412, 325414

The Department of State’s notice concerns an annual sole-source order for Sanofi influenza vaccines for the 2026–2027 flu season.
- **Award and value:** A $68,964 firm-fixed-price delivery order is described for Sanofi Pasteur under VA Federal Supply Schedule contract 36F79722D0104.
- **Products:** High-dose Fluzone and Flublok influenza vaccines for immunocompromised embassy family members. The notice does not state quantities or part numbers.
- **Delivery requirements:** Vaccines require cold-chain storage and distribution to embassies and consulates before the flu season.
- **Competition rationale:** The justification states that Sanofi is the only manufacturer of the specified proprietary vaccines; the order is planned as a sole-source procurement.

### Description

<p>Fluzone and Flublok Influenza Vaccines for the 2026-2027 Flu season. The vaccine is required to immunize embassy immunocompromised family members.&nbsp;</p>

[View original listing](https://sam.gov/opp/3b3938d3903047c3a5c5d497dc988711/view)
